2373.HK HKSE
Beauty Farm Medical and Health Industry Inc.
1W: +5.5%
1M: +6.6%
3M: +6.9%
YTD: -24.3%
1Y: -34.5%
3Y: +4.5%
HK$19.00 ($2.42)
-0.40 (-2.06%)
Weekly Expected Move ±7.6%
HK$16
HK$18
HK$19
HK$21
HK$22
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$797M
+27.4% ▲
5Y CAGR: +11.4%
Capital Expenditures
$114M
+28.3% ▲
5Y CAGR: +1.2%
Free Cash Flow
$682M
+46.4% ▲
5Y CAGR: +13.9%
Dividends Paid
$112M
-29.3% ▼
Buybacks
$0
+100.0% ▲
Net Change in Cash
$232M
+285.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $189M | $255M | $130M | $288M | $318M |
| Depreciation & Amort. | $259M | $275M | $297M | $332M | $0 |
| Stock-Based Comp. | $7M | $6M | $14M | $11M | -$384K |
| Change in Working Capital | $246M | $174M | -$46M | $35M | $101M |
| Other Non-Cash Items | $26M | $24M | -$13M | -$40M | $378M |
| Operating Cash Flow | $681M | $670M | $382M | $626M | $797M |
| — Investing Activities — | |||||
| Capital Expenditures | -$68M | -$133M | -$141M | -$159M | $0 |
| Acquisitions (Net) | -$26M | -$8M | -$6M | -$8M | $0 |
| Investment Purchases | $0 | $0 | -$1.4B | -$2.2B | $0 |
| Investment Sales | $0 | $0 | $1.6B | $1.6B | $0 |
| Other Investing | -$276M | -$245M | $219K | $7M | -$341M |
| Investing Cash Flow | -$369M | -$385M | $54M | -$711M | -$341M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$13M | -$6M | -$231M | -$232M | -$116M |
| Stock Repurchased | $0 | $0 | $0 | -$12M | $0 |
| Dividends Paid | -$107M | -$81M | -$204M | -$87M | -$112M |
| Other Financing | -$154M | -$184M | -$1M | -$42M | $5M |
| Financing Cash Flow | -$273M | -$271M | -$433M | $134M | -$223M |
| Net Change in Cash | $39M | $14M | $7M | $60M | $232M |
| Cash End of Period | $144M | $157M | $164M | $224M | $456M |
| Free Cash Flow | $613M | $537M | $241M | $466M | $682M |